Palo Alto Longevity Prize: a million dollars to slow aging

    As you know, not so long ago, Google founded a subsidiary company Calico , which deals with immortality, or, if simpler, the "treatment of old age." Google and partner companies (one of them is the pharmaceutical giant from Chicago, AbbVie Corporation) have enough finances to support research of any scale and intensity. Currently, investment in Calico is one and a half billion US dollars.

    However, one of these days another project was announced to combat old age and death. It's about the Palo Alto Longevity PrizeThe size of which is 1 million US dollars. The prize was announced in San Francisco, and it will be awarded to a scientist or team who can cope with the two identified issues (respectively, a scientist or team receives 500 thousand US dollars for each issue).

    The first question, or more precisely, the problem, is the restoration of the heart rate in an "elderly" animal (we are not talking about a person yet) to the indicators of the period of youth. Scientists believe that such a result is possible only in the event of a return of "youthful homeostasis."

    The second problem is an increase in the life span of the animal by 50% .

    Moreover, verification of the results will be carried out by comparing the data in experimental animals with the data of the control group of animals of the same species. Unfortunately, it is still unknown what kind of animal in question.

    Any team of scientists can participate in the competition, but there is also a control factor: those who wish should pay an entry fee in the amount of 1,000 to 2,000 US dollars, the amount of the contribution depends on the time of registration.

    The results of the study on the first problem should be received no later than June 2016, for the second - no later than September 2018.

    Already, 11 research teams have expressed a desire to participate in the project:

    Doris Taylor, Ph.D.
    Heart Institute texas, Houston, the TX
    TEAM the NAME: THI Regenerative MEDICINE (Approach: STem cells)
    Dongsheng of Cai, MD, Ph.D.
    Albert Einstein College of Medicine, New York, NY
    TEAM NAME: CAI LAB (approach: hypothalamic regulation) Andreas Birkenfeld, MD
    Charite University School of Medicine, Berlin, Germany
    http: //
    TEAM NAME: INDY (approach: gene modification)
    Jin Hyung Lee, Ph.D.
    Stanford University, Palo Alto, CA
    TEAM NAME: LEE LAB (approach: neuromodulation)
    David Mendelowitz, Ph.D.
    George Washington University, Washington, DC
    TEAM NAME: MENDELOWITZ LAB (approach: oxytocin)
    Scott Wolf, MD
    Mountain View, CA / volts-medical /
    TEAM NAME: VOLTS MEDICAL (approach: inflammatory tissues)
    Irving Zucker, Ph.D.
    Nebraska You will of Medical University then Center, the Omaha, the NE TEAM
    the NAME: ZUCKER LAB (Approach: neuromodulation)
    Brian Olshansky, MD
    University of Iowa Medical Center, Iowa City, IA
    TEAM NAME: IOWA PRO-AUTONOMIA (approach: not yet public)
    William Sarill, MA
    Arlington, MA
    http: // TEAM
    the NAME: DECO (Approach: by the pituitary hormones)
    Steven Porges, Ph.D.
    University of North Carolina, Chapel Hill, NC
    (approach: optimizing both the left & right vagal branches)
    Shin-Ichiro Imai, MD, Ph .D.
    Washington University, St. Louis, MO
    TEAM NAME: IMAI LAB (approach: gene modification)

    Also popular now: